Journal of International Oncology››2014,Vol. 41››Issue (8): 708-711.doi:10.3760/cma.j.issn.1673-422X.2014.09.019
Previous ArticlesNext Articles
Ren Huiwen, Yang Cheng, Su Hongwei, Li Hongwei
Online:2014-09-25Published:2014-09-05Contact:Li Hongwei E-mail:lihw@163.comRen Huiwen, Yang Cheng, Su Hongwei, Li Hongwei. Predictive effect of microRNA ratio in osteosarcoma[J]. Journal of International Oncology, 2014, 41(8): 708-711.
| ［1］ Geller DS, Gorlick R. Osteosarcoma: a review of diagnosis, management, and treatment strategies［J］. Clin Adv Hematol Oncol, 2010, 8(10): 705-718. ［2］ NanaSinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer［J］. Transl Res, 2011, 157(4): 216-225. ［3］ Kobayashi E, Hornicek FJ, Duan Z. MicroRNA involvement in osteosarcoma［J］. Sarcoma, 2012, 2012: 359739. ［4］ SitaLumsden A, Dart DA, Waxman J, et al. Circulating microRNAs as potential new biomarkers for prostate cancer ［J］. Br J Cancer, 2013, 108(10): 1925-1930. ［5］ Gordon GJ, Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma［J］. Cancer Res, 2002, 62(17): 4963-4967. ［6］ HajAhmad TA, Abdalla MA, HajAhmad Y. Potential urinary miRNA biomarker candidates for the accurate detection of prostate cancer among benign prostatic hyperplasia patients［J］. J Cancer, 2014, 5(3): 182-191. ［7］ Fassina A, Cappellesso R, Simonato F, et al. A 4MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears［J］. Cancer Cytopathol, 2014, 122(4): 274-281. ［8］ Fortunato O, Boeri M, Verri C, et al. Assessment of circulating microRNAs in plasma of lung cancer patients［J］. Molecules, 2014, 19(3): 3038-3054. ［9］ Avissar M, Christensen BC, Kelsey KT, et al. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma［J］. Clin Cancer Res, 2009, 15(8): 2850-2855. |
| [1] | Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311. |
| [2] | Wang Zihao, Wang Yu, Yang Xin, He Yi, Mo Xingkui, Yuan Tao.Research progress on the molecular mechanism and related treatments of ferroptosis in osteosarcoma[J]. Journal of International Oncology, 2024, 51(4): 239-244. |
| [3] | Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190. |
| [4] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
| [5] | Ma Xiaoping, Chang Junli, Sun Xingyuan, Yang Yanping.Study progression on mechanism of long non-coding RNAs regulating drug resistance in osteosarcoma[J]. Journal of International Oncology, 2023, 50(1): 51-54. |
| [6] | Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198. |
| [7] | Jin Jiahui, Chen Cunhai, Ma Xuezhen.Effects of radiation-associated miRNA in radiotherapy for breast cancer[J]. Journal of International Oncology, 2022, 49(12): 735-738. |
| [8] | Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686. |
| [9] | Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis[J]. Journal of International Oncology, 2022, 49(1): 45-50. |
| [10] | Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64. |
| [11] | Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis[J]. Journal of International Oncology, 2021, 48(7): 409-414. |
| [12] | Wang Yang, Liu Qian, Long Hui, Wu Qingming.Research status of fecal detection for colorectal cancer markers[J]. Journal of International Oncology, 2021, 48(7): 441-444. |
| [13] | Cheng Yiming, Li Gang, Wang Zhenming, Lyu Qianwen, Li Shirong.Value of serum miR-196a-5p and miR-105-5p in differential diagnosis of benign and malignant pulmonary nodules[J]. Journal of International Oncology, 2021, 48(5): 282-286. |
| [14] | Deng Bo'er, Kong Weimin.Epigenetic research progress of endometrial cancer[J]. Journal of International Oncology, 2021, 48(3): 184-188. |
| [15] | Li Bingliang, Yang Ya, Huang Yingli, Si Wen, Li Xingwei, Zhang Yuanmin, Bian Jichao, Chen Yu.Effects of miR-20a-5p targeting KDM6B on the proliferation, migration and invasion of osteosarcoma cells[J]. Journal of International Oncology, 2021, 48(2): 65-73. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
